These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The Impact of the CX3CL1/CX3CR1 Axis in Neurological Disorders. Pawelec P, Ziemka-Nalecz M, Sypecka J, Zalewska T. Cells; 2020 Oct 13; 9(10):. PubMed ID: 33065974 [Abstract] [Full Text] [Related]
14. Fractalkine/CX3CR1 signalling in chronic pain and inflammation. Clark AK, Staniland AA, Malcangio M. Curr Pharm Biotechnol; 2011 Oct 13; 12(10):1707-14. PubMed ID: 21466443 [Abstract] [Full Text] [Related]
15. LRRK2 modulates microglial activity through regulation of chemokine (C-X3-C) receptor 1 -mediated signalling pathways. Ma B, Xu L, Pan X, Sun L, Ding J, Xie C, Koliatsos VE, Cai H. Hum Mol Genet; 2016 Aug 15; 25(16):3515-3523. PubMed ID: 27378696 [Abstract] [Full Text] [Related]
17. Fractalkine aggravates LPS-induced macrophage activation and acute kidney injury via Wnt/β-catenin signalling pathway. Gong Q, Jiang Y, Pan X, You Y. J Cell Mol Med; 2021 Jul 15; 25(14):6963-6975. PubMed ID: 34101346 [Abstract] [Full Text] [Related]